ELIZABETH MOYER: Open Payments
NPI 1073157475 · TEMPLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 20 payments from 8 companies in 2025. Trend: 2023 $335 · 2024 $467 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $354 |
| SCPHARMACEUTICALS INC. | 4 | $195 |
| Madrigal Pharmaceuticals | 1 | $150 |
| PFIZER INC. | 4 | $93 |
| E.R. Squibb & Sons, L.L.C. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: CARDIOMEMS, FUROSCIX, REZDIFFRA, ELIQUIS, CAMZYOS, LifeVest, LOKELMA, LEQVIO.
Industry payments across PA — which companies pay providers there.
